ADMA Biologics Inc. Comparables
Find the most relevant public market comparables for ADMA Biologics Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
ADMA Biologics Inc. is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
Business Model
ADMA Biologics operates through three segments: ADMA BioManufacturing (immune globulin manufacturing and development), Plasma Collection Centers (source plasma collection facilities), and Corporate (general and administrative overhead). The company manufactures and markets plasma-derived biologics, and also sells plasma-derived intermediate fractions and provides laboratory contracting services.
Target Customers
Physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases; immune-compromised individuals with underlying immune deficiency disorders or those medically immune-suppressed.
Specific Focus
Specialty plasma-derived biologics for the treatment of immune deficiencies and prevention of infectious diseases in immune-compromised patients.
Location
Ramsey, New Jersey
CEO
Adam S. Grossman
Industry
Life sciences
Sub Sector
Plasma-derived biologics
3yr Revenue Growth
512%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to ADMA Biologics Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for ADMA Biologics Inc.? Our platform provides detailed analysis of ADMA Biologics Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full ADMA Biologics Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full ADMA Biologics Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, ADMA Biologics Inc. operates in the specialized Plasma-derived biologics sub-sector. Understanding how ADMA Biologics Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Plasma-derived biologics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of ADMA Biologics Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free